Back to Search

BELINDA RENE AVALOS MD

MD

Hematology (Internal Medicine) Physician

NPI: 1467726828Individual

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

2012-02350(NC)
Hematology & Oncology Physician

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

2012-02350(NC)
Medical Oncology Physician

Internal Medicine — Medical Oncology

Code: 207RX0202X

2012-02350(NC)
Hematology (Internal Medicine) PhysicianPrimary

Internal Medicine — Hematology

Code: 207RH0000X

2012-02350(NC)

Research & Publications (20)

HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo.
PMID 17892546·Genet Vaccines Ther·2007
8-other
Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous leukemia.
PMID 19539217·Biol Blood Marrow Transplant·2009
3-trial
Role of the proteasome in modulating native G-CSFR expression.
PMID 18554923·Cytokine·2008
7-preclinical
Divergent pathways in COS-7 cells mediate defective internalization and intracellular routing of truncated G-CSFR forms in SCN/AML.
PMID 18560579·PLoS One·2008
7-preclinical
Changing concepts in the pathogenesis, evaluation, and management of solitary rectal ulcer syndrome.
PMID 18942624·Am Surg·2008
4-observational
G-CSFR ubiquitination critically regulates myeloid cell survival and proliferation.
PMID 18923646·PLoS One·2008
8-other
LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU.1 and C/EBPepsilon that modulate neutrophil activation.
PMID 18272588·J Leukoc Biol·2008
7-preclinical
High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma.
PMID 17070906·Leuk Res·2007
8-other
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
PMID 17162217·Biol Blood Marrow Transplant·2006
8-other
High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation.
PMID 16399569·Biol Blood Marrow Transplant·2006
4-observational
Diffuse alveolar hemorrhage following gemtuzumab ozogamicin.
PMID 15735659·Bone Marrow Transplant·2005
5-case
Syngeneic vs. allotransplantation in chronic myeloid leukemia: all's well that ends well.
PMID 16082344·Transplantation·2005
5-case
Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia.
PMID 15353486·Blood·2005
5-case
Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes.
PMID 15657182·Blood·2005
8-other
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia.
PMID 15711571·Bone Marrow Transplant·2005
3-trial
Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia.
PMID 15470047·J Immunol·2004
8-other
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.
PMID 15156164·Bone Marrow Transplant·2004
3-trial
Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged >or=50 years compared to younger adults with low-risk disease.
PMID 12621488·Bone Marrow Transplant·2003
4-observational
Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor.
PMID 14587040·Am J Hematol·2003
7-preclinical
Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation.
PMID 12223515·J Leukoc Biol·2002
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via CAROLINAS HEALTHCARE SYSTEM · 4 locations total

Address
1021 MOREHEAD MEDICAL DR, STE A
CHARLOTTE, NC 28204
Practice locations map

Locations (4)

CAROLINAS HEALTHCARE SYSTEM

1021 MOREHEAD MEDICAL DR, CHARLOTTE, NC
(980) 442-2000

THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY

4525 CAMERON VALLEY PKWY, CHARLOTTE, NC
(704) 302-8300

THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY

447 MCALISTER RD, LINCOLNTON, NC
(980) 212-5100

THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY

1550 FAULK ST, MONROE, NC
(980) 442-0430

Quick Facts

NPI
1467726828
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
4
Locations
4
Publications
20

Are you this provider?

Claim Your Profile